Company: MDCXW
Filing Date: 2025-05-30
Form Type: 424B4
Source: 0001062993-25-010548
Chunk: 232

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-30
Form: 424B4
Chunk 232
---
 |     |   |             - |     |   |               - |     |   | (5,102,408  | ) |   | (5,102,408 | ) |
| Balance as of March 31, 2025                                                                              |     | 13,417,561 |     | $ |    32,908,702 |     | $ |       3,245,163 |     | $ | (34,006,311 | ) | $ |  2,147,554 |   |
|                                                                                                           |     |            |     |   | Common shares |     |   |      Additional |     |   | Accumulated |   |   |            |   |
|                                                                                                           |     |     Shares |     |   |        Amount |     |   | paid-in capital |     |   | deficit     |   |   |      Total |   |
| Balance as of December 31, 2023                                                                           |     |  8,076,673 |     | $ |    18,761,250 |     | $ |          98,585 |     | $ | (17,748,387 | ) | $ |  1,111,448 |   |
| Stock-based compensation                                                                                  |     |          - |     |   |             - |     |   |          35,953 |     |   | -           |   |   |     35,953 |   |
| Net loss and comprehensive loss for the period                                                            |     |          - |     |   |             - |     |   |               - |     |   | (1,707,358  | ) |   | (1,707,358 | ) |
| Balance as of March 31, 2024                                                                              |     |  8,076,673 |     | $ |    18,761,250 |     | $ |         134,538 |     | $ | (19,455,745 | ) | $ |   (559,957 | ) |

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

<div align='center'>F-27

MEDICUS PHARMA LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)</div>

| Cash flows from operating activities:                                                    |   | Three months ended March 31, 
                         2025 |   |   |